Swift Biosciences

Swift Biosciences is a life science company specializing in the development of innovative library preparation kits for next-generation sequencing (NGS). The company's products are designed to enhance the sensitivity and efficiency of genomic sequencing across various applications, including oncology, liquid biopsy, and metagenomics. Their proprietary technologies, such as Accel-NGS and Swift Normalase, streamline workflows and enable high-quality data generation from challenging samples like low-input DNA and formalin-fixed paraffin-embedded (FFPE) tissues. In 2021, Swift Biosciences was acquired by Integrated DNA Technologies (IDT), a Danaher company, to expand its genomic research portfolio. The integration allows for a broader range of solutions for researchers working in genomics and molecular biology.